1. Yuan, Peng, Yang, Tao, Mu, Jiao, Zhang, Hongxin, Li, Jibin. 2019. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells. In Cancer letters, 469, 498-509. doi:10.1016/j.canlet.2019.11.024. https://pubmed.ncbi.nlm.nih.gov/31765736/
2. Zheng, Xiaojiao, Lv, Xiuyi, Zhu, Linyan, Cui, Lining, Ding, Huiqing. 2021. The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma. In Cancer management and research, 13, 9329-9343. doi:10.2147/CMAR.S343097. https://pubmed.ncbi.nlm.nih.gov/34992456/
3. He, Yiwei, Wang, Gang, Wang, Qian, Zhang, Zhaohui, Zhou, Feng. 2021. Genetic variants in NPAS2 gene and clinical outcomes of resectable non-small-cell lung cancer. In Future oncology (London, England), 17, 795-805. doi:10.2217/fon-2020-0211. https://pubmed.ncbi.nlm.nih.gov/33541123/
4. Ma, Shuaijun, Chen, Yafan, Quan, Penghe, Jia, Weijing, Qin, Weijun. 2023. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling. In BMC cancer, 23, 280. doi:10.1186/s12885-023-10685-w. https://pubmed.ncbi.nlm.nih.gov/36978001/
5. Cao, Xiao-Meng, Kang, Wen-Di, Xia, Tian-Hong, Wang, Wen-Jie, Liu, Hong-Bin. . High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study. In World journal of gastroenterology, 29, 3645-3657. doi:10.3748/wjg.v29.i23.3645. https://pubmed.ncbi.nlm.nih.gov/37398880/
智鼠故事 
